Imbruvica Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Each film-coated tablet contains 140 mg of ibrutinib.
Excipients with known effect: Each 140 mg film-coated tablet contains 28 mg of lactose monohydrate.
Excipients/Inactive Ingredients: Tablet core: Colloidal anhydrous silica, Croscarmellose sodium, Lactose monohydrate, Magnesium stearate, Microcrystalline cellulose, Povidone, Sodium lauril sulfate (E487).
Film-coat: Macrogol, Polyvinyl alcohol, Talc, Titanium dioxide (E171), Black iron oxide (E172), Yellow iron oxide (E172).

ibrutinib

Manufacturer:

Johnson & Johnson

Distributor:

DCH Auriga - Healthcare

Four Star